Back to Gene
CLPP gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

CLPP gene

The CLPP gene provides instructions for making a protein essential for breaking down abnormally folded proteins within the mitochondria.

Normal Function

The CLPP gene provides instructions for making the ClpP subunit protein. Multiple copies of this protein interact with each other to form a barrel-shaped chamber known as the ClpP complex. This complex is one of two parts of the ClpXP protease, which breaks down abnormally folded proteins. The other part of the ClpXP protease, called the ClpX complex, unfolds the abnormal proteins and feeds them into the chamber formed by the ClpP complex, where they are broken down into small fragments.

The ClpP complex is found in structures in the cell called mitochondria, which are the energy-producing centers of cells.

Health Conditions Related to Genetic Changes

Perrault syndrome

At least three mutations in the CLPP gene have been found in families with Perrault syndrome, a condition characterized by hearing loss in affected males and females and abnormalities of the ovaries in affected females. The CLPP gene mutations involved in Perrault syndrome likely alter the structure of the barrel-shaped chamber formed by the ClpP complex. These changes may impair the breakdown of misfolded mitochondrial proteins, which could impact mitochondrial function; however, it is unclear how these changes lead to the features of Perrault syndrome.

Other Names for This Gene

  • ATP-dependent Clp protease proteolytic subunit, mitochondrial
  • ATP-dependent protease ClpAP, proteolytic subunit, human
  • ClpP caseinolytic peptidase ATP-dependent, proteolytic subunit
  • ClpP caseinolytic protease, ATP-dependent, proteolytic subunit homolog
  • endopeptidase Clp
  • PRLTS3
  • putative ATP-dependent Clp protease proteolytic subunit, mitochondrial

Frequently Asked Questions

Currently, no disease‑specific therapy exists. Management focuses on symptomatic care: hearing rehabilitation, fertility counseling, and monitoring for other mitochondrial‑related complications. Research into mitochondrial‑targeted antioxidants or gene‑therapy approaches is ongoing but not yet clinically available.
Diagnosis involves a combination of audiologic testing, ovarian imaging or hormone profiling in females, and genetic testing. Targeted sequencing of the CLPP gene can detect pathogenic variants; a positive result confirms the diagnosis.
Early intervention with hearing aids or cochlear implants can improve communication. Regular audiologic follow‑up is essential to adjust amplification as hearing changes over time. Speech‑language therapy may also be beneficial.
Patients typically present with sensorineural hearing loss that may start in childhood or adolescence, and women may experience ovarian dysgenesis leading to primary amenorrhea or infertility. Some families also report neurological symptoms such as ataxia or developmental delays.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab